Abbott recently presented some preliminary two-year results on its bioabsorbable stent study. The results show that the stent “successfully treated coronary artery disease and was absorbed into the walls of treated arteries within two years, leaving behind blood vessels that appeared to move and function similar to unstented arteries.” Read the press release.
Maybe this is the “leapfrog” technology for treating coronary artery disease?
